Compare Elder Pharma with AANJANEYA LIFECARE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ELDER PHARMA vs DR. DATSONS LABS - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ELDER PHARMA DR. DATSONS LABS ELDER PHARMA/
DR. DATSONS LABS
 
P/E (TTM) x -0.2 -10.9 - View Chart
P/BV x 0.1 0.2 62.2% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 ELDER PHARMA   DR. DATSONS LABS
EQUITY SHARE DATA
    ELDER PHARMA
Jun-14
DR. DATSONS LABS
Mar-14
ELDER PHARMA/
DR. DATSONS LABS
5-Yr Chart
Click to enlarge
High Rs380126 302.5%   
Low Rs18831 608.4%   
Sales per share (Unadj.) Rs491.2133.0 369.3%  
Earnings per share (Unadj.) Rs-3.20.2 -2,098.5%  
Cash flow per share (Unadj.) Rs14.46.6 218.1%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs376.5128.8 292.3%  
Shares outstanding (eoy) m20.5431.66 64.9%   
Bonus/Rights/Conversions -FCCB-  
Price / Sales ratio x0.60.6 98.3%   
Avg P/E ratio x-89.3516.1 -17.3%  
P/CF ratio (eoy) x19.711.8 166.4%  
Price / Book Value ratio x0.80.6 124.1%  
Dividend payout %00-   
Avg Mkt Cap Rs m5,8332,477 235.5%   
No. of employees `000NANA-   
Total wages/salary Rs m2,17956 3,891.1%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m10,0894,211 239.6%  
Other income Rs m25779 326.0%   
Total revenues Rs m10,3464,289 241.2%   
Gross profit Rs m-792569 -139.3%  
Depreciation Rs m361204 176.8%   
Interest Rs m2,756430 640.7%   
Profit before tax Rs m-3,65313 -28,763.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m0-2 0.0%   
Extraordinary Inc (Exp) Rs m3,7130-   
Tax Rs m1256 2,051.6%   
Profit after tax Rs m-655 -1,361.5%  
Gross profit margin %-7.813.5 -58.1%  
Effective tax rate %-3.448.0 -7.1%   
Net profit margin %-0.60.1 -568.2%  
BALANCE SHEET DATA
Current assets Rs m9,2406,852 134.9%   
Current liabilities Rs m9,9986,711 149.0%   
Net working cap to sales %-7.53.3 -224.3%  
Current ratio x0.91.0 90.5%  
Inventory Days Days46161 28.8%  
Debtors Days Days60318 18.8%  
Net fixed assets Rs m10,1243,673 275.6%   
Share capital Rs m206317 65.0%   
"Free" reserves Rs m5,5823,761 148.4%   
Net worth Rs m7,7344,078 189.7%   
Long term debt Rs m4,8891,671 292.6%   
Total assets Rs m22,88212,633 181.1%  
Interest coverage x-0.31.0 -31.6%   
Debt to equity ratio x0.60.4 154.3%  
Sales to assets ratio x0.40.3 132.3%   
Return on assets %11.83.4 341.5%  
Return on equity %-0.80.1 -717.8%  
Return on capital %22.37.7 290.7%  
Exports to sales %3.022.9 13.3%   
Imports to sales %0.414.3 3.0%   
Exports (fob) Rs m307964 31.8%   
Imports (cif) Rs m43602 7.2%   
Fx inflow Rs m307964 31.8%   
Fx outflow Rs m125607 20.6%   
Net fx Rs m181357 50.8%   
CASH FLOW
From Operations Rs m11,7541,345 874.0%  
From Investments Rs m-561-2,256 24.8%  
From Financial Activity Rs m-6,762-1,200 563.6%  
Net Cashflow Rs m4,432-2,111 -210.0%  

Share Holding

Indian Promoters % 39.6 4.5 874.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 7.5 0.0 -  
FIIs % 16.8 1.4 1,244.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 36.1 94.1 38.4%  
Shareholders   16,479 20,807 79.2%  
Pledged promoter(s) holding % 77.6 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ELDER PHARMA With:   PANACEA BIOTECH  BIOCON   FULFORD INDIA  JUBILANT LIFE SCIENCES  AJANTA PHARMA  

Compare ELDER PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Higher; Telecom and Energy Stocks Gain the Most(09:30 am)

Asian share markets are lower today as Chinese and Hong Kong shares fall. The Shanghai Composite is off 0.4% while the Hang Seng is down 0.7%.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

The Smartest Stock to Buy for 2020(Profit Hunter)

Nov 14, 2019

Small-cap stocks are selling at bargain prices today and are poised to generate a lot of wealth in 2020 and beyond...

Why Moody's Rating Downgrade is a Strong Sign to Buy Stocks(The 5 Minute Wrapup)

Nov 8, 2019

Investors who took cues from Moody's rating downgrade in 1992 and 2002 created some of the biggest wealth of their lifetime.

A Trade that Could Generate Profits for Decades

Nov 14, 2019

India's #1 trader is back on the Investor Hour. Vijay Bhambwani talks to us about his super-profitable trading system and shares with us his #1 long term trade. Listen in...

The One Trade I'm Most Bullish on Now

Nov 12, 2019

A highly specific trade to potentially triple your money in just three months. You won't find this information anywhere else!

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ELDER PHARMA SHARE PRICE


Sep 12, 2016 (Close)

TRACK ELDER PHARMA

  • Track your investment in ELDER PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ELDER PHARMA 5-YR ANALYSIS

COMPARE ELDER PHARMA WITH

MARKET STATS